Rebecca Badawi1, Lina El Murr2 and Georges El Hachem3*
1Internal Medicine Resident, Department of Internal Medicine, Saint George Hospital University Medical Center, Beirut, Lebanon 2Hematology and Medical Oncology Fellow, Department of Hematology and Medical Oncology, Saint George Hospital University Medical Center, Beirut, Lebanon 3Hematologist and Medical Oncologist, Department of Hematology and Medical Oncology, Saint George Hospital University Medical Center and Assistant Professor of Clinical Medicine, University of Balamand, Lebanon
*Corresponding Author: Georges El Hachem, Hematologist and Medical Oncologist, Department of Hematology and Medical Oncology, Saint George Hospital University Medical Center and Assistant Professor of Clinical Medicine, University of Balamand, Lebanon.
Received: November 10, 2021; Published: November 25, 2021
In 1985, the American Cancer Society declared October as National Breast Cancer Awareness Month. In the same year, the incidence of breast cancer in females was estimated at 719,000 ranking it the first among all cause cancer in women [1]. Since then, it has increased to 2,261,419 cases in 2020 [2]. This raise in incidence is attributed to improved awareness which lead to increased screening. In addition, the 5-year survival rate improved from an estimated 74 percent in 1985 to 90 percent in 2017, a consequence of early detection and advances in treatment modalities [3,4].
Citation: Georges El Hachem., et al. “Pink October Like No Other: When PINK Turns into Black". Acta Scientific Cancer Biology 5.12 (2021): 17-18.
Copyright: © 2021 Georges El Hachem., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.